In our study, we confirmed that administration of CLE decreased mucus hypersecretion in a mouse model of COPD, and decreased the mRNA levels of MUC5AC, MUC5B and MUC5AC protein production in in vitro experiments. This evidence concerns the gene MUC5AC and chronic obstructive pulmonary disease.